SCHEMBL11926959

SCHEMBL11926959

N#Cc1ccc(C(=O)OCC(=O)NCCCCC(NC(=O)COC(=O)c2ccc(C#N)cc2)C(=O)O)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 2/20 0.44
▸ KMT2A Q03164 5/20 0.43
▸ ALB P02768 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ C3AR1 Q16581 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ NTRK1 P04629 1/20 0.41
▸ NTRK2 Q16620 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ ADRB2 P07550 1/20 0.41
▸ ADRB1 P08588 1/20 0.41
▸ ADRB3 P13945 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11926960 0.85 NPC1 (0.52) KMT2AKDM4EMAPTHTTNPC1
SCHEMBL15259411 0.83 ALB (0.42) FOLH1KMT2AALBKDM4EMAPT
SCHEMBL11926962 0.81 LMNA (0.37) KMT2AKDM4EMAPTHTTNPC1
SCHEMBL20040297 0.78 KMT2A (0.41) KMT2AKDM4EMAPTHTTNPC1
SCHEMBL20040343 0.75 KMT2A (0.39) KMT2AKDM4EMAPTHTTNPC1
SCHEMBL15006373 0.72 KMT2A (0.40) KMT2AKDM4EMAPTHTTNPC1
SCHEMBL20040445 0.71 KMT2A (0.52) KMT2AKDM4EMAPTHTTNPC1
SCHEMBL20546624 0.70 MEN1 (0.49) FOLH1KMT2AALBC3AR1MEN1
SCHEMBL17981439 0.70 MEN1 (0.49) FOLH1KMT2AALBC3AR1MEN1
SCHEMBL20040345 0.70 KMT2A (0.38) KMT2AKDM4EMAPTHTTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120208896-A1 AMINO ACID DERIVATIVES AND ABSORABLE POLYMERS THEREFROM BEZWADA BIOMEDICAL, LLC. (US) 2012-08-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208896-A1 AMINO ACID DERIVATIVES AND ABSORABLE POLYMERS THEREFROM SLC7A1, SLC3A2, BCAT2 FOLH1 906/4885KMT2A 1401/4885ALB 1438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback